Status:
COMPLETED
Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto
Lead Sponsor:
innoVactiv Inc.
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
50-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if the combination of 2007RD01, a natural extract, and saw palmetto lipidic extract, is more effective at treating lower urinary tract symptoms associated wit...
Eligibility Criteria
Inclusion
- Patient must be an adult man aged between 50 and 75
- Patient must have Benign Prostatic Hyperplasia symptoms
Exclusion
- Patient has a malfunction of the urinary tract, is suffering from acute urinary retention, or is suffering from prostate cancer or urinary tract infection
- Patient has been subjected to surgery of the prostate, bladder or urethra
- Patient has taken a 5-alpha-reductase inhibitor in the 6-month period preceding screening
- Patient has taken an alpha-blocker in the 2-week period preceding screening
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00797394
Start Date
November 1 2008
Last Update
April 13 2011
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Recherches Cliniques Theradev
Granby, Quebec, Canada, J2G 8Z9
2
Urology South Shore Research
Greenfield Park, Quebec, Canada, J4V 2H3
3
Les Urologues Associés du CHUM
Montreal, Quebec, Canada, H2X 1N8
4
Clinique d'urologie Berger
Québec, Quebec, Canada, G1S 2L6